The Supreme Court has affirmed the demand notice issued by the National Pharmaceutical Pricing Authority (NPPA) against Sun Pharma, involving a penalty of Rs 4.65 crore for the overpricing of its antibacterial drug, Roscilox. This decision comes after Sun Pharma contested the notices dating back to 2005, which called for the company to reimburse Rs
